Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
α-Adrenergic receptor modulates 5-HT-mediated behavioral effects of MDMA and psilocybin in mice.Molecular psychiatry · 2026-11-01Psilocin fosters neuroplasticity in iPSC-derived human cortical neuronseLife · 2026-03-27Psilocin fosters neuroplasticity in iPSC-derived human cortical neuronsResearch Square · 2026-01-07Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch NegativitybioRxiv · 2025-11-07Divergent effects of ketamine and psilocybin on EEG power spectral density in a mismatch negativity paradigmUniversität Zürich, ZORA · 2025-11-05[Acceptance of psilocybin-assisted therapy in German-speaking countries].Der Nervenarzt · 2025-11-01Akzeptanz psilocybin-assistierter Therapie in den deutschsprachigen Ländernedoc Publication server (Humboldt University of Berlin) · 2025-02-12The Afterglow Inventory (AGI) - validation of a new instrument for measuring subacute effects of classic serotonergic psychedelicsPsyArXiv · 2024-10-22The Afterglow Inventory (AGI) - validation of a new instrument for measuring subacute effects of classic serotonergic psychedelicsPsyArXiv · 2024-10-22Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch NegativityResearch Square · 2024-09-26Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin.Med (New York, N.Y.) · 2024-03-08The Altered Xperience Project (AXP): Quantitative and Qualitative Data from a Citizen Science Initiative on the Subjective Experience of Altered States of ConsciousnessPsyArXiv · 2023-06-04The Altered Xperience Project (AXP): Quantitative and Qualitative Data from a Citizen Science Initiative on the Subjective Experience of Altered States of ConsciousnessPsyArXiv · 2023-06-04ID: 212703 Augmenting rTMS With Psilocybin-Assisted Psychotherapy (PAP) for PTSD: A Proof-of-Concept Study DesignNeuromodulation Technology at the Neural Interface · 2023-06-01[Attitudes of Mental Health Experts Towards Psilocybin].Fortschritte der Neurologie-Psychiatrie · 2023-03-01The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics.Therapeutic advances in psychopharmacology · 2023-01-01Phenomenological assessment of psychedelics induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI).PloS one · 2022-01-01Systematized Review of Psychotherapeutic Components of Psilocybin-Assisted Psychotherapy.American journal of psychotherapy · 2021-12-01Phenomenological assessment of psychedelic induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI)PsyArXiv · 2021-04-02Phenomenological assessment of psychedelic induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI)PsyArXiv · 2021-04-02Dose-response relationships of psilocybin-induced subjective experiences in humans.Journal of psychopharmacology (Oxford, England) · 2021-04-01How does it feel to be on psilocybin? Dose-response relationships of subjective experiences in humansbioRxiv · 2020-06-11[Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].Fortschritte der Neurologie-Psychiatrie · 2017-07-01Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.Journal of psychopharmacology (Oxford, England) · 2016-12-01The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity.NeuroImage. Clinical · 2016-01-01Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?Journal of psychopharmacology (Oxford, England) · 2015-03-01Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin.Cerebral cortex (New York, N.Y.: 1991) · 2014-12-01Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations.The Journal of neuroscience: the official journal of the Society for Neuroscience · 2013-06-19Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on α Oscillations, N170 Visual-Evoked Potentials, and Visual HallucinationsOpen MIND · 2013-01-01The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions.Psychopharmacology · 2013-01-01Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.Biological psychiatry · 2012-12-01Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2012-03-01